These findings revealed a new role of PHLPP2 in lung cancer, showing that LUAD tissue with TRIM46 amplification had decreased levels of PHLPP2, leading to increased levels of p-AKT which promotes glycolysis. Here, TRIM46 is linked to lung cancer.